Detalhe da pesquisa
1.
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Brain
; 138(Pt 12): 3632-53, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490331
2.
A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.
J Neurosci
; 32(44): 15426-38, 2012 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23115180
3.
(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease.
Biochim Biophys Acta
; 1812(11): 1371-9, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21867751
4.
The calpain-suppressing effects of olesoxime in Huntington's disease.
Rare Dis
; 4(1): e1153778, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141414
5.
Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro.
Neuropharmacology
; 108: 24-38, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27133377
6.
Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.
Mol Neurobiol
; 50(1): 107-18, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24633813
7.
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance.
Cell Metab
; 11(4): 273-85, 2010 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20374960